Abdul Bureh Kamara🇸🇱

The Pharmaceutical Sector Laid Bare In #SierraLeone, a pill can be a lifeline—or a death sentence. With a population of 8.3 million, the country teeters on the edge of a pharmaceutical abyss, its health system crippled by dependency, dysfunction, and a regulatory free-for-all that leaves citizens vulnerable. The COVID-19 pandemic ripped the veil off this shocking reality, exposing a nation with no local drug manufacturing, a Pharmacy Board drowning in corruption, and streets awash with peddled poison. This is not just a crisis—it’s a betrayal of trust. A Nation at the Mercy of Imports Picture this - a global pandemic hits, borders close, flights grind to a halt. For most countries, this is a logistical headache. For Sierra Leone, it’s a death knell. As Conteh et al. reveal in their 2022 study, Sierra Leone has zero pharmaceutical manufacturing companies. None. Every tablet, every syringe, every vaccine dose comes from abroad. When COVID-19 struck, import restrictions triggered “severe drug shortages and medicine insecurity,” leaving hospitals and pharmacies empty-handed. The Ebola outbreak a decade earlier had already sounded the alarm—yet nothing changed. A single manufacturing company once existed here, but it shuttered over 20 years ago, and no roadmap exists to revive it. Compare that to Nigeria’s 165 manufacturers or even Zimbabwe’s eight, and the scale of Sierra Leone’s vulnerability becomes stark. This dependency isn’t just a supply issue—it’s a gateway to disaster. Substandard and falsified medicines flood the market, exploiting a nation with no means to produce its own. The authors warn that excessive reliance on imports “provides an opportunity for falsified and substandard medicines to enter the legitimate supply chain.” And enter they do—often with deadly consequences. A Pharmacy Board in Shambles If the lack of manufacturing is the wound, the Pharmacy Board of Sierra Leone (PBSL) is the infection. Once a bastion of order under a competent former Registrar, it’s now a crumbling relic, gutted by political meddling and incompetence. Insiders paint a grim picture - a Registrar, appointed not for skill but for loyalty, compromises on “situations that need stringent actions.” Staff who dare to enforce the rules—per their sworn oaths—are demoted or sidelined. When importers are caught with substandard drugs, a phone call from a political heavyweight ensures the evidence vanishes. “The whole pharmaceutical sector is a mess,” the commentary declares, “they talk endlessly about the challenges but never resort to solutions.” The numbers tell a damning story. With too few pharmacists for 8 million people, most work in cushy roles at PBSL, NGOs, or hospitals, not in community pharmacies. Those who do often “rent” their licenses for exorbitant fees—sometimes a year’s salary upfront—while rarely setting foot on the premises. Proprietors, desperate to keep shops running, exploit this laxity, leaving pharmacies staffed by unqualified technicians or even nurses, despite regulations forbidding it. Only 2% of pharmacies have a professional in a white coat; some attendants are shirtless, handing out antibiotics like candy. Prescription? Optional. Oversight? Nonexistent. Lawlessness on Every Corner The Pharmacy Drugs Act of 2001 is clear: no drug advertising, no prescription sales by non-pharmacies, no doctors running their own drugstores. Yet, reality mocks the law. Drug peddlers roam streets and buses with loudspeakers, hawking expired and substandard wares—often supplied by importers with PBSL’s tacit approval. Patent stores sprout like weeds, secretly selling prescription drugs and undercutting legitimate pharmacies forced to pay high rents and license fees. Doctors at private clinics flout Section 18, stocking pharmacies illegally, while nurses in government hospitals hoard drugs in toilets, extorting poor patients seeking free care. PBSL’s own rules—pharmacies shouldn’t cluster—lie in tatters. Streets are lined with competing shops, thanks to political overrides of staff objections. Conflicts of interest fester. PBSL employees own pharmacies, inspecting themselves with a wink and a nod. The kush crisis spirals, yet the Board and Pharmaceutical Society sit dormant, targeting thriving pharmacies instead of tackling the chaos. “Everyone is allowed to do what they feel like doing,” the commentary fumes, and the Pharmacy Drugs Act might as well be confetti. The Human Cost This isn’t abstract. It’s personal. Every fake pill swallowed, every antibiotic misused, every peddler’s shout risks lives. The poor, women, and children bear the brunt, as the World Health Organization (WHO) notes half of #Africa’s population lacks regular medicine access. Sierra Leone’s failures amplify this tragedy. #Ebola and #COVIDー19 were wake-up calls, but the snooze button’s been hit too long. There is a lifeline - tax breaks for importers to build local factories, sub-factories from Nigeria or Ghana, land grants, and purchase agreements with the National Medicines Supply Agency. But without dismantling the PBSL’s rot, these are pipe dreams. The regulatory overview touts a “comprehensive” drug approval process and Good Manufacturing Practices—on paper. In practice, resource shortages, corruption, and ignorance strangle enforcement. #Ghana and #Nigeria show what’s possible with stricter licensing and @WHO collaboration. Sierra Leone must follow, training nurses for pharmacies, jailing peddlers, and purging political cronies from the PBSL. Sierra Leoneans deserve better. A functional pharmaceutical sector isn’t a luxury—it’s a right. We crave a profession respected, not ridiculed; rules upheld, not broken by the rulemakers. The government must act—build factories, clean house at PBSL, enforce the law. Citizens must demand it. Walk into a pharmacy today and ask: is this pill real? The answer shouldn’t be a gamble. The shocking reality is out—now, let’s shock the system into change.